WHO ICTRP trial

Comparative bioavailability of diclofenac epolamine tablets vs. Flector®…

ISRCTN50053717 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN50053717
Public title Comparative bioavailability of diclofenac epolamine tablets vs. Flector® granules for oral solution in healthy volunteers, pilot study in fed conditions
Scientific title Comparative bioavailability of diclofenac epolamine tablets vs. Flector® granules for oral solution in healthy volunteers, pilot study in fed conditions
Primary sponsor IBSA Institut Biochimique SA
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Switzerland
Conditions Diclofenac epolamine (DHEP) 50 mg soluble tablets containing 65 mg of diclofenac epolamine corresponding to 50 mg of diclofenac sodium Not Applicable
Interventions Test product (T): Diclofenac epolamine (DHEP) 50 mg soluble tablets containing 65 mg of diclofenac epolamine corresponding to 50 mg of diclofenac sodium Reference therapy (R): Flector® granules for oral solution, 50 mg sachets containing 65…
Registration date Oct 11, 2017
Target size 24
Secondary IDs Study CRO-PK-16-312 - Sponsor code 16CH-GIB04
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations